Quest Diagnostics (DGX) Treasury Shares (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Treasury Shares data on file, last reported at $5.1 billion in Q1 2026.

• Quarterly Treasury Shares rose 6.28% year-over-year to $5.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 billion (up 6.28% YoY) and the FY2025 annual result came in at $5.2 billion, up 6.65% from the prior year.
• Treasury Shares fell to $5.1 billion in Q1 2026 per DGX's latest filing, from $5.2 billion in the prior quarter.
• The five-year high for Treasury Shares was $52.0 million in Q4 2025, with the low at $1.1 million in Q4 2022.
• Average Treasury Shares over 5 years is $28.7 million, with a median of $50.0 million recorded in 2023.
• The widest YoY moves for Treasury Shares: up 49.02% in 2022, down 43.41% in 2022.
• Quest Diagnostics' Treasury Shares stood at $4.7 billion in 2022, then grew by 3.27% to $4.8 billion in 2023, then climbed by 0.64% to $4.9 billion in 2024, then gained by 6.65% to $5.2 billion in 2025, then decreased by 1.72% to $5.1 billion in 2026.
• Business Quant data shows DGX's Treasury Shares at $5.1 billion in Q1 2026, $5.2 billion in Q4 2025, and $4.9 billion in Q3 2025.